Skip to content
MedCompare

Dolutegravir

Also known as Tivicay (us)

HIV & PrEP
Infections
Save $3,156/mo
1619× cheaper

Dolutegravir is used to treat human immunodeficiency virus (HIV) infection. Dolutegravir is in a class of medications called HIV integrase inhibitors.

United States
$3,158
per month
India
$2
per month
You save
$3,156
99.94% cheaper in India
255.8K US scripts/yr$807.1M potential annual savings$807.6M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC20H19F2N3O5

SMILES: C[C@@H]1CCO[C@@H]2N1C(=O)C3=C(C(=O)C(=CN3C2)C(=O)NCC4=C(C=C(C=C4)F)F)O

Compare the price
US price$3,158per month
India price$2per month
You save$3,15699.94% less

Based on 30 EAs per month. US $105.25 vs India $0.07 per EA.

Total over 1 periodSave $3,156$3,158 → $2
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$18,934
Estimated travel cost
− $2,300
Net savings after travel
$16,634

Even after travel, you could come out ahead by about $16,634.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Dolutegravir is filled about 255.8K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$807.6M
If sourced from India
$498.7K
Potential annual savings
$807.1M
−100%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.